Scholar Rock Holding SRRK
NASDAQ SRRK
$42.81 -0.19 (-0.45%)
As of: Oct 22, 2026 · 10:04 AM EDT

Scholar Rock Holding (SRRK) Capital Leases (2018)

Updated

Scholar Rock Holding (SRRK) posted Capital Leases of $28,000 for Q3 2018.

Analysis

Scholar Rock Holding (SRRK) Capital Leases (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,163.48 Bn 1,132.06 Bn 19.71 Bn
2 Johnson & Johnson 631.16 Bn 549.69 Bn 17.26 Bn
3 AbbVie 502.63 Bn 475.74 Bn 12.70 Bn
4 Merck 378.53 Bn 332.91 Bn 12.21 Bn
5 Novartis Ag 302.83 Bn 266.82 Bn 11.24 Bn
6 Astrazeneca 265.92 Bn 239.60 Bn 12.86 Bn
7 Amgen 240.87 Bn 196.27 Bn 7.24 Bn
8 Gilead Sciences 194.04 Bn 168.24 Bn 6.22 Bn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn
10 Scholar Rock Holding 5.59 Bn 3.88 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 28,000.00
API Access

Scholar Rock Holding Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=SRRK&period=max&api_key=YOUR_API_KEY